Brain ischemia induced release of peroxiredoxin 6 into cerebrospinal fluid.
Toll-like receptor 4 and peroxiredoxin 6 levels were increased in ischemic brain.
Ligustilide attenuated postischemic neuroinflammation and brain injury.
Ligustilide reduced Toll-like receptor 4/peroxiredoxin 6 in ischemic brain.
Toll-like receptor 4 signaling was inhibited by ligustilide.